{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T01:27:12Z","timestamp":1781054832653,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,8,18]],"date-time":"2012-08-18T00:00:00Z","timestamp":1345248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00345-012-0927-9","type":"journal-article","created":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T05:05:07Z","timestamp":1345179907000},"page":"305-311","source":"Crossref","is-referenced-by-count":45,"title":["Diagnostic significance of [\u22122]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0\u201310.0\u00a0ng\/mL range"],"prefix":"10.1007","volume":"31","author":[{"given":"Kazuto","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Miyakubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,18]]},"reference":[{"key":"927_CR1","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","volume":"324","author":"WJ Catalona","year":"1991","unstructured":"Catalona WJ, Smith DS, Ratliff TL et al (1991) Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324:1156\u20131161","journal-title":"N Engl J Med"},{"key":"927_CR2","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","volume":"151","author":"WJ Catalona","year":"1994","unstructured":"Catalona WJ, Richie JP, Ahmann FR et al (1994) Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: result of a multicenter trial of 6,630 men. J Urol 151:1283\u20131290","journal-title":"J Urol"},{"key":"927_CR3","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/jama.1995.03530150038031","volume":"274","author":"WJ Catalona","year":"1995","unstructured":"Catalona WJ, Smith DS, Wolfert RL et al (1995) Evaluation of percentage of free serum prostate specific antigen to improve specificity of prostate cancer screening. JAMA 274:1214\u20131220","journal-title":"JAMA"},{"key":"927_CR4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0022-5347(01)65847-6","volume":"156","author":"AF Prestigiacomo","year":"1996","unstructured":"Prestigiacomo AF, Lilja H, Pettersson K, Wolfert RL, Stamey TA (1996) A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best-case scenario. J Urol 156:350\u2013354","journal-title":"J Urol"},{"key":"927_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0090-4295(96)00611-5","volume":"48","author":"AW Partin","year":"1996","unstructured":"Partin AW, Catalona WJ, Southwick PC, Subong EN, Gasior GH, Chan DW (1996) Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology 48:55\u201361","journal-title":"Urology"},{"key":"927_CR6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(20000815)89:4<842::AID-CNCR17>3.0.CO;2-9","volume":"89","author":"E Kikuchi","year":"2000","unstructured":"Kikuchi E, Nakashima J, Ishibashi M et al (2000) Prostate specific antigen adjusted for transition zone volume: the most powerful method for detecting prostate carcinoma. Cancer 89:842\u2013849","journal-title":"Cancer"},{"key":"927_CR7","first-page":"3111","volume":"57","author":"A Kumar","year":"1997","unstructured":"Kumar A, Mikolajczyk SD, Goel AS, Millar LS, Saedi MS (1997) Expression of pro form of prostate specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res 57:3111\u20133114","journal-title":"Cancer Res"},{"key":"927_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0090-4295(03)00138-9","volume":"62","author":"TY Chan","year":"2003","unstructured":"Chan TY, Mikolajczyk SD, Lecksell K et al (2003) Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigen. Urology 62:177\u2013181","journal-title":"Urology"},{"key":"927_CR9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/pros.20872","volume":"69","author":"C Stephan","year":"2009","unstructured":"Stephan C, Kahrs AM, Cammann H et al (2009) A [\u22122]pro-PSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases. Prostate 69:198\u2013207","journal-title":"Prostate"},{"key":"927_CR10","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1158\/1055-9965.EPI-10-0007","volume":"19","author":"LJ Sokoll","year":"2010","unstructured":"Sokoll LJ, Sanda MG, Feng Z et al (2010) A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [\u22122]pro-PSA: improving prostate cancer detection and correlating with cancer aggressiveness. Cancer Epidemiol Biomarkers Prev 19:1193\u20131200","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"927_CR11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1442-2042.2009.02304.x","volume":"16","author":"M Miyakubo","year":"2009","unstructured":"Miyakubo M, Ito K, Yamamoto T, Takechi H, Ohi M, Suzuki K (2009) Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy. Int J Urol 16:561\u2013565","journal-title":"Int J Urol"},{"key":"927_CR12","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.juro.2009.12.056","volume":"183","author":"BV Le","year":"2010","unstructured":"Le BV, Griffin CR, Loeb S et al (2010) [\u22122]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study. J Urol 183:1355\u20131359","journal-title":"J Urol"},{"key":"927_CR13","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.juro.2010.12.032","volume":"185","author":"WJ Catalona","year":"2011","unstructured":"Catalona WJ, Partin AW, Sanda MG et al (2011) A multicenter study of [\u22122]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0\u00a0ng\/ml prostate specific antigen range. J Urol 185:1650\u20131655","journal-title":"J Urol"},{"key":"927_CR14","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/cncr.10941","volume":"95","author":"K Ito","year":"2002","unstructured":"Ito K, Ohi M, Yamamoto T et al (2002) The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1\u201310.0\u00a0ng\/ml. Cancer 95:2112\u20132119","journal-title":"Cancer"},{"key":"927_CR15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/pcan.2011.62","volume":"15","author":"M Nomura","year":"2012","unstructured":"Nomura M, Ito K, Miyakubo M et al (2012) Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy-adjusted and prostate volume-adjusted biopsy scheme. Prostate Cancer Prostatic Dis 15:202\u2013209","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"927_CR16","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1464-410X.2003.04733.x","volume":"93","author":"CH Bangma","year":"2004","unstructured":"Bangma CH, Wildhagen MF, Yurdakul G, Schr\u00f6der FH, Blijenberg BG (2004) The value of (\u22127, \u22125) pro-prostate-specific antigen and human kallikrein-2 as serum markers for grading prostate cancer. BJU Int 93:720\u2013724","journal-title":"BJU Int"},{"key":"927_CR17","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.eururo.2006.04.011","volume":"50","author":"C Stephan","year":"2006","unstructured":"Stephan C, Meyer HA, Kwiatkowski M et al (2006) A (\u22125, \u22127) pro-PSA-based artificial neural network to detect prostate cancer. Eur Urol 50:1014\u20131020","journal-title":"Eur Urol"},{"key":"927_CR18","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1097\/01.ju.0000181221.72017.ca","volume":"174","author":"M Lein","year":"2005","unstructured":"Lein M, Semjonow A, Graefen M et al (2005) A multicenter clinical trial on the use of (\u22125, \u22127) pro prostate specific antigen. J Urol 174:2150\u20132153","journal-title":"J Urol"},{"key":"927_CR19","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1097\/01.ju.0000127737.94221.3e","volume":"171","author":"WJ Catalona","year":"2004","unstructured":"Catalona WJ, Bartsch G, Rittenhouse HG et al (2004) Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4\u00a0ng\/mL prostate specific antigen. J Urol 171:2239\u20132244","journal-title":"J Urol"},{"key":"927_CR20","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0022-5347(17)38508-7","volume":"145","author":"MK Terris","year":"1991","unstructured":"Terris MK, Stamey TA (1991) Determination of prostate volume by transrectal ultrasound. J Urol 145:984\u2013987","journal-title":"J Urol"},{"key":"927_CR21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF02550959","volume":"28","author":"I Alkan","year":"1996","unstructured":"Alkan I, T\u00fcrkeri L, Biren T, Cevik I, Akda\u015f A (1996) Volume determinations by transrectal ultrasonography in patients with benign prostatic hyperplasia: correlation with removed prostate weight. Int Urol Nephrol 28:517\u2013523","journal-title":"Int Urol Nephrol"},{"key":"927_CR22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.juro.2007.09.083","volume":"179","author":"E Rodriguez Jr","year":"2008","unstructured":"Rodriguez E Jr, Skarecky D, Narula N, Ahlering TE (2008) Prostate volume estimation using the ellipsoid formula consistently underestimates actual gland size. J Urol 179:501\u2013503","journal-title":"J Urol"},{"key":"927_CR23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.clinbiochem.2010.04.062","volume":"43","author":"A Semjonow","year":"2010","unstructured":"Semjonow A, K\u00f6pke T, Eltze E et al (2010) Pre-analytical in vitro stability of [\u22122]pro-PSA in blood and serum. Clin Biochem 43:926\u2013928","journal-title":"Clin Biochem"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-012-0927-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-012-0927-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-012-0927-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T18:55:32Z","timestamp":1562093732000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-012-0927-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,18]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["927"],"URL":"https:\/\/doi.org\/10.1007\/s00345-012-0927-9","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,18]]}}}